Search results
Results from the WOW.Com Content Network
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies , and the largest private one.
Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
And Boehringer Ingelheim is making it available to all Americans, regardless of insurance status," Gemmell said. Cyltezo will sell for $550, a 92% discount from the Humira list price of about $7,000.
Volasertib (also known as BI 6727) is an experimental small molecule inhibitor of the PLK1 (polo-like kinase 1) protein being developed by Boehringer Ingelheim for use as an anti-cancer agent. Volasertib is the second in a novel class of drugs called dihydropteridinone derivatives. [1]
There are other bird flu vaccines that are licensed in the US, too, including one from German company Boehringer-Ingelheim that has been used in other countries, including France and Mexico.
Ofev: Boehringer Ingelheim's non-small-cell lung cancer treatment. Tradjenta: Boehringer Ingelheim's diabetes drug. Linzess: AbbVie's irritable bowel syndrome treatment.
Pages in category "Drugs developed by Boehringer Ingelheim" The following 30 pages are in this category, out of 30 total. This list may not reflect recent changes .